Literature DB >> 26219859

Exploring naturally occurring ivy nanoparticles as an alternative biomaterial.

Yujian Huang1, Yi-Jun Wang2, Yongzhong Wang1, Sijia Yi3, Zhen Fan1, Leming Sun1, Derrick Lin4, Nagaraju Anreddy2, Hua Zhu5, Michael Schmidt4, Zhe-Sheng Chen2, Mingjun Zhang6.   

Abstract

Arabinoglactan protein (AGP)-rich nanoparticles obtained from the sticky exudates of Hedera helix (English ivy), have shown promising potential to be used in nanomedicine owing to their excellent aqueous solubility, low intrinsic viscosity, biocompatibility, and biodegradability. In this study, the feasibilities of utilizing ivy nanoparticles (INPs) as nano-carriers for delivering chemotherapeutic drugs in cancer therapy and as nano-fillers to develop novel scaffolds for tissue engineering in regenerative medicine are evaluated. Via electrostatic and hydrophobic interactions, pH-responsive nanoconjugates are formed between the INPs and the doxorubicin (DOX) with an entrapment ratio of 77.9±3.9%. While the INPs show minimal cytotoxicity, the formed INP-DOX conjugates exhibit substantially stronger cytotoxic activity than free DOX against multiple cancer cell lines, suggesting a synergistic effect is established upon conjugation. The anti-cancer effects of the INP-DOX conjugates are further evaluated via in vivo xenograft assays by subcutaneously implanting DOX resistant cell line, SW620/Ad-300, into nude mice. The tumor volumes in mice treated with the INP-DOX conjugates are significantly less than those of the mice treated with free DOX. In addition, the INPs are further exploited as nano-fillers to develop fibrous scaffolds with collagen, via mimicking the porous matrix where the INPs are embedded under natural condition. Enhanced adhesion of smooth muscle cells (SMCs) and accelerated proliferation of mouse aortic SMCs are observed in this newly constructed scaffold. Overall, the results obtained from the present study suggest great potential of the INPs to be used as biocompatible nanomaterials in nanomedicine. The AGP-rich INP renders a glycoprotein architecture that is amenable for modification according to the functional designs, capable of being developed as versatile nanomaterials for extensive biomedical applications. STATEMENT OF SIGNIFICANCE: Naturally occurring organic nanomaterials have drawn increasing interest for their potential biomedical applications in recent years. In this study, a new type of naturally occurring nanoparticles obtained from the sticky exudates on the adventitious roots of English ivy (H. helix), was explored for its potential biomedical application. In particular, the feasibilities of utilizing ivy nanoparticles (INPs) as nano-carriers for delivering chemotherapeutic drugs in cancer therapy and as nano-fillers to develop novel scaffolds for tissue engineering in regenerative medicine were evaluated both in vitro and in vivo. Overall, the results obtained from the present study suggest the great potential of the INPs to be used as biocompatible nanomaterials in nanomedicine. This study may open a totally new frontier for exploring the biomedical application of naturally occurring nanomaterials.
Copyright © 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bio-inspiration; Biocompatibility; Drug delivery; Ivy nanoparticle; Tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 26219859     DOI: 10.1016/j.actbio.2015.07.035

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  10 in total

1.  Natural Nano-Drug Delivery System in Coptidis Rhizoma Extract with Modified Berberine Hydrochloride Pharmacokinetics.

Authors:  Jing Zhao; Qing Zhao; Jing-Ze Lu; Dan Ye; Sheng Mu; Xiao-Di Yang; Wei-Dong Zhang; Bing-Liang Ma
Journal:  Int J Nanomedicine       Date:  2021-09-14

2.  Modular Fabrication of Intelligent Material-Tissue Interfaces for Bioinspired and Biomimetic Devices.

Authors:  John R Clegg; Angela M Wagner; Su Ryon Shin; Shabir Hassan; Ali Khademhosseini; Nicholas A Peppas
Journal:  Prog Mater Sci       Date:  2019-07-17

Review 3.  Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.

Authors:  Erika Dosekova; Jaroslav Filip; Tomas Bertok; Peter Both; Peter Kasak; Jan Tkac
Journal:  Med Res Rev       Date:  2016-11-15       Impact factor: 12.944

4.  Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin.

Authors:  Yi-Jun Wang; Yujian Huang; Nagaraju Anreddy; Guan-Nan Zhang; Yun-Kai Zhang; Meina Xie; Derrick Lin; Dong-Hua Yang; Mingjun Zhang; Zhe-Sheng Chen
Journal:  Oncotarget       Date:  2016-02-02

Review 5.  Recent advancements in erythrocytes, platelets, and albumin as delivery systems.

Authors:  Peipei Xu; Ruju Wang; Xiaohui Wang; Jian Ouyang
Journal:  Onco Targets Ther       Date:  2016-05-17       Impact factor: 4.147

6.  Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.

Authors:  Wei-Liang Chen; Fang Li; Yan Tang; Shu-di Yang; Ji-Zhao Li; Zhi-Qiang Yuan; Yang Liu; Xiao-Feng Zhou; Chun Liu; Xue-Nong Zhang
Journal:  Int J Nanomedicine       Date:  2017-06-06

Review 7.  Synergistic Mechanisms of Constituents in Herbal Extracts during Intestinal Absorption: Focus on Natural Occurring Nanoparticles.

Authors:  Qing Zhao; Xin Luan; Min Zheng; Xin-Hui Tian; Jing Zhao; Wei-Dong Zhang; Bing-Liang Ma
Journal:  Pharmaceutics       Date:  2020-02-03       Impact factor: 6.321

Review 8.  Bio-based and bio-inspired adhesives from animals and plants for biomedical applications.

Authors:  Theresa M Lutz; Ceren Kimna; Angela Casini; Oliver Lieleg
Journal:  Mater Today Bio       Date:  2022-01-12

Review 9.  Current development of biodegradable polymeric materials for biomedical applications.

Authors:  Richard Song; Maxwell Murphy; Chenshuang Li; Kang Ting; Chia Soo; Zhong Zheng
Journal:  Drug Des Devel Ther       Date:  2018-09-24       Impact factor: 4.162

10.  Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In Vivo.

Authors:  Guan-Nan Zhang; Pranav Gupta; Ming Wang; Anna Maria Barbuti; Charles R Ashby; Yun-Kai Zhang; Leli Zeng; Qiaobing Xu; Ying-Fang Fan; Zhe-Sheng Chen
Journal:  Cancers (Basel)       Date:  2020-02-21       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.